Please check your internet connection and try again.
### Sompraz hp (esomeprazole)
## Overview
Sompraz hp is a combination product containing esomeprazole (a proton pump inhibitor) and two antibiotics (amoxicillin and clarithromycin), typically used for the eradication of *Helicobacter pylori* (*H. pylori*). Esomeprazole reduces stomach acid production, which enhances the effectiveness of the antibiotics.
## Primary Indications
* Eradication of *Helicobacter pylori* (*H. pylori*) infection in patients with peptic ulcer disease (gastric or duodenal ulcers).
## Adult Dosing
The typical regimen is one Sompraz hp pack taken twice daily for 7-14 days, as prescribed by the healthcare provider. Each pack usually contains:
* Esomeprazole 20 mg capsule
* Amoxicillin 500 mg capsule
* Clarithromycin 250 mg tablet
**Note:** Dosing duration and specific components may vary based on local guidelines and prescriber preference.
## Pediatric Dosing
There is **limited established pediatric dosing** for this specific combination product. Dosing for *H. pylori* eradication in children is often individualized based on weight and age, and may utilize separate antibiotic and PPI formulations. Consult pediatric-specific guidelines and resources.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for esomeprazole, amoxicillin, or clarithromycin in mild to moderate renal impairment. Caution may be advised in severe renal impairment.
* **Hepatic Impairment:** In severe hepatic impairment, the dose of esomeprazole may need to be reduced. Specific recommendations for the combination product are not well-defined; consider individual component dosing adjustments.
## Contraindications
* Known hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or other proton pump inhibitors, penicillins, or macrolides.
* History of allergic reactions to penicillins or cephalosporins.
* Concomitant use with certain drugs such as rifampicin, nelfinavir, astemizole, terfenadine, cisapride, pimozide, and ergot alkaloids.
* Severe hepatic impairment (for esomeprazole component).
## Adverse Effects
Common adverse effects may include:
* Diarrhea, nausea, abdominal pain, taste disturbances (metallic taste)
* Headache, dizziness
* Allergic reactions (rash, itching)
* *Clostridioides difficile*-associated diarrhea
## Key Drug Interactions
* **Clarithromycin:** Can inhibit CYP3A4, increasing levels of drugs metabolized by this enzyme (e.g., simvastatin, lovastatin, carbamazepine, cisapride).
* **Esomeprazole:** Can inhibit CYP2C19 and CYP3A4, affecting the metabolism of other drugs (e.g., clopidogrel, warfarin, phenytoin, diazepam).
* **Amoxicillin:** Generally has fewer significant drug interactions, but can affect gut flora.
* **Antacids and Sucralfate:** May decrease the absorption of esomeprazole; separate administration by at least 2 hours.
## Monitoring
* Monitor for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms).
* Assess for adverse drug reactions.
* Monitor for signs of *Clostridioides difficile*-associated diarrhea.
* For patients on long-term PPI therapy, monitor for potential nutrient deficiencies (e.g., vitamin B12, magnesium) and bone fractures.
## Clinical Pearls
* Administer the entire contents of one pack twice daily before a meal.
* Ensure the full course of therapy is completed to maximize eradication rates and minimize resistance.
* *H. pylori* eradication should be confirmed with a validated non-invasive test (e.g., urea breath test, stool antigen test) typically 4-6 weeks after completion of therapy.
* Advise patients on the potential for antibiotic resistance if the full course is not completed.
***
*This information is intended for educational purposes and does not substitute for professional medical advice. Always consult the most current prescribing information and guidelines before making any treatment decisions.*
